STOCK TITAN

Drugs Made In America II: Karpus reports 5.18% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Drugs Made In America Acquisition II Corp. (DMII) is the issuer whose common shares Karpus Management, Inc. reported beneficially owning: 3,300,023 shares, or 5.18%, as of September 30, 2026. The shares are owned directly by accounts managed by Karpus. Karpus stated it exercises voting and investment power independently of its parent, City of London Investment Group plc, under informational barriers, and that beneficial ownership attribution between them is not required.

Beneficial ownership 3,300,023 shares DMII common stock; as of September 30, 2026
Percent of class 5.18% DMII common stock; as of September 30, 2026
beneficially owned regulatory
"Amount beneficially owned: 3,300,023.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power regulatory
"Sole Voting Power 3,300,023.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"Sole Dispositive Power 3,300,023.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
registered investment adviser regulatory
"Karpus is a registered investment adviser"
A registered investment adviser (RIA) is a firm or individual legally registered with regulators to give personalized investment advice and manage clients' money, with a duty to put clients’ interests ahead of their own. Think of an RIA as a licensed financial guide who must disclose fees, conflicts and how they are paid; that transparency and legal duty matter to investors because it reduces the risk of hidden costs or biased recommendations.
informational barriers regulatory
"effective informational barriers have been established"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DMII shares did Karpus Management report owning?

Karpus Management reported beneficial ownership of 3,300,023 common shares, or 5.18%, as of September 30, 2026. The shares are owned directly by accounts managed by Karpus.

Was Karpus Management’s DMII stake attributed to its parent, City of London Investment Group?

Karpus stated that it exercises voting and investment power independently of City of London Investment Group plc under informational barriers, and that beneficial ownership attribution between the two is not required.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





G2851K104

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



KARPUS MANAGEMENT, INC.
Signature:/s/ Jodi L. Hedberg
Name/Title:Jodi L. Hedberg / Chief Compliance Officer
Date:11/13/2026

Keep reading